Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Unfavorable phase III results lead to setback in CerAxon development

April 22, 1998

Orphan drug designation granted for Xerecept

April 21, 1998

Heterocyclic tachykinin antagonists from Sanofi

April 21, 1998

Dainippon presents a BZP inverse agonist for the treatment of dementia

April 21, 1998

MS&D discovers agents for safely enhancing cognition

April 21, 1998

New data reported for donepezil hydrochloride

April 21, 1998

Collaborations formed to further development of memantine

April 21, 1998

New data confirms efficacy of Zomig

April 20, 1998

Chiesi prepares new anticonvulsants and neuroprotective agents

April 20, 1998

Sertraline: a selective serotonin reuptake inhibitor for the treatment of PMDD

April 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...